Fluorouracil: all 820 studies that test it

Page 3 of 9. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryCompletedNCT00777491Phase 2Results posted
• A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00756444Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerTerminatedNCT00707473Phase 2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• Measuring Adherence To Topical 5-Fluorouracil in a Clinic PopulationCompletedNCT00696488Phase 4Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast CancerCompletedNCT00615901Not applicableResults posted
• Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerTerminatedNCT00611858Phase 2Results posted
• Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedNCT00609765Phase 2Results posted
• Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00608205Phase 3Results posted
• Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or StomachCompletedNCT00601705Phase 2Results posted
• Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)TerminatedNCT00599131Phase 2Results posted
• Proton Radiotherapy With Chemotherapy for Nasopharyngeal CarcinomaCompletedNCT00592501Phase 2Results posted
• Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaCompletedNCT00591123Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT00588770Phase 3Results posted
• Optimized Intensity Modulated Irradiation for Head and Neck CancerCompletedNCT00580983Not applicableResults posted
• Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric CancerCompletedNCT00555672Phase 1Results posted
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction PatientsCompletedNCT00526110Phase 1/2Results posted
• Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)CompletedNCT00525785Phase 2Results posted
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
• Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
• Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00514020Phase 2Results posted
• Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00467142Phase 2Results posted
• Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic CancerTerminatedNCT00463840Phase 1/2Results posted
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerCompletedNCT00462735Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.CompletedNCT00448136Phase 2Results posted
• A Trial of Chemo & Radiation Therapy for Pancreatic CancerCompletedNCT00424827Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerCompletedNCT00423293Phase 2Results posted
• Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas CancerCompletedNCT00417976Phase 2Results posted
• Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal CancerCompletedNCT00408694Phase 2Results posted
• Study of Induction Docetaxel, Cisplatin and 5-FluorouracilTerminatedNCT00400205Phase 2Results posted
• A Safety and Efficacy Study in Patients With Gastric CancerCompletedNCT00400179Phase 3Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
• Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer PatientsCompletedNCT00354978Phase 2Results posted
• A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTerminatedNCT00352118Phase 2Results posted
• Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck CancerCompletedNCT00352105Phase 1/2Results posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By SurgeryCompletedNCT00321828Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerCompletedNCT00316888Phase 2Results posted
• 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal CancerCompletedNCT00308516Phase 2Results posted
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal CancerCompletedNCT00307736Phase 1/2Results posted
• Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerCompletedNCT00217737Phase 3Results posted
• Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00199797Phase 1Results posted
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT00193219Phase 2Results posted
• Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal CancerCompletedNCT00143403Phase 3Results posted
• Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)CompletedNCT00122460Phase 3Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00113399Phase 3Results posted
• Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedNCT00111761Phase 2Results posted
• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00098787Phase 2Results posted
• Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)CompletedNCT00095875Phase 3Results posted
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerCompletedNCT00087178Phase 3Results posted
• S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) JunctionCompletedNCT00086996Phase 2Results posted
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon CancerCompletedNCT00079274Phase 3Results posted
• A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerTerminatedNCT00064259Phase 1/2Results posted
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal CancerCompletedNCT00057785Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder CancerCompletedNCT00055601Phase 2Results posted
• High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat CancerCompletedNCT00052429Phase 1/2Results posted
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerCompletedNCT00014222Phase 3Results posted
• Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and ChemotherapyCompletedNCT00004547Phase 2Results posted
• Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerCompletedNCT00003298Phase 2Results posted
• Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00002842Phase 2Results posted
• Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically RemovedTerminatedNCT00002525Phase 3Results posted
• Bladder Preservation or Cystectomy for MIBCActive, not recruitingNCT07821177Early Phase 1
• A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT07257575Phase 2
• DPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer PatientsCompletedNCT06782022Phase 2
• Intraoperative 5-fluorouracil Augmentation of TrabeculectomyCompletedNCT06745856Phase 3
• Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCATerminatedNCT06739252Phase 2
• Carac & PDT Combination in the Treatment Of Actinic KeratosesCompletedNCT06712381Phase 1/2
• Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomasActive, not recruitingNCT06557889Phase 2
• Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal CancerWithdrawnNCT06501989Phase 2
• Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn ManagementWithdrawnNCT06362226Phase 1
• Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer PatientsTerminatedNCT06332079Phase 2
• Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal CancerActive, not recruitingNCT06269978Phase 1
• Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the PancreasCompletedNCT06225999Phase 2
• 5-fluorouracil for Treatment of Stable VitiligoCompletedNCT06209138Not applicable
• Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic DacryocystitisCompletedNCT06175676Phase 1
• Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabActive, not recruitingNCT06107413Phase 2
• NEO-adjuvant Chemo-immunotherapy in Pancreatic CancerActive, not recruitingNCT06094140Phase 2
• PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCCompletedNCT06062602Early Phase 1
• Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT05721755Phase 3
• Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaActive, not recruitingNCT05715931Phase 2
• Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical SurgeryActive, not recruitingNCT05713838Phase 2
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant RecipientsActive, not recruitingNCT05699603Phase 2
• Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar WartsStatus unknownNCT05520658Not applicable
• Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.CompletedNCT05513924Phase 2/3
• Intralesional 5-fluorouracil Injection for the Treatment of Oral LeukoplakiaWithdrawnNCT05505539Phase 1
• Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric AdenocarcinomaCompletedNCT05504720Phase 2
• 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East AfricaCompletedNCT05362955Phase 1
• A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesActive, not recruitingNCT05329766Phase 2
• Efficacy of Tazarotene in Treatment of Verruca PlanaStatus unknownNCT05314127Phase 2
• Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWithdrawnNCT05296005Phase 1

← Fluorouracil overview